Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis
- PDF / 2,032,730 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 187 Views
20) 12:75
Diabetology & Metabolic Syndrome Open Access
RESEARCH
Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta‑analysis Bianca de Almeida‑Pititto1,2,3*, Patrícia M. Dualib2,3,4, Lenita Zajdenverg2,5, Joana Rodrigues Dantas5, Filipe Dias de Souza3, Melanie Rodacki2,5 and Marcello Casaccia Bertoluci2,6,7 on behalf of Brazilian Diabetes Society Study Group (SBD)
Abstract Background: The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severity (inva‑ sive mechanical ventilation or intensive care unit admission or O2 saturation
Data Loading...
